Study of the Safety of PIM447 in Combination With Ruxolitinib (INC424) and LEE011 in Patients With Myelofibrosis
Clinical trial NCT02370706 · COMPLETED
Trial details
- NCT number
- NCT02370706
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-21
- Primary completion
- 2020-11-09
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.